EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats.
Zhang, Wenbin a,b; Welihinda, Ajith c,1; Mechanic, Jordan c,2; Ding, Haifeng b; Zhu, Liangcheng b; Lu, Yuan b; Deng, Zhongping b; Sheng, Zelin b; Lv, Binhua b; Chen, Yuanwei b; Roberge, Jacques Y. b; Seed, Brian b,c,**; Wang, Yong-Xiang a,b,*
[Article]
Pharmacological Research.
63(4):284-293, April 2011.
(Format: HTML, PDF)
(C) 2011Elsevier, Inc.